Press Releases
Hybrigenics and Servier enter into a licence and research collaboration agreement in oncology and other therapeutic fields
Hybrigenics (ALHYG), a bio-pharmaceutical company listed on Alternext (NYSE-Euronext) in Paris, and Servier, the largest French privately-owned pharmaceutical company, announces today that they have signed a licence and research collaboration agreement in the field of deubiquitinating enzymes (DUBs) applied...
Press Releases
Global Bio-Pharma Clinical Leaders Call for Industry Transformation at 21st Annual Partnerships in Clinical Trials
Clinical development, outsourcing and operations decision makers from the world’s top bio-pharmaceutical and medical device manufacturers and their clinical research partners will meet on March 4-7, 2012 at the 21st Annual Partnerships in Clinical Trials (PCT) conference in Orlando,...
Press Releases
Genetic Technologies Limited Appoints Dr. Mervyn Cass as Company Director
The Board of Directors of Genetic Technologies Limited has with great pleasure appointed Dr. Mervyn Cass as a non-executive Director of the Company. Dr. Cass is a practicing medical practitioner and, after 28 years as the senior partner in...
Press Releases
IBA’s Family of Proton Beam Solutions Suits Diverse Budgets, Sites and Clinical Needs
IBA Particle Therapy now offers a range of Proton Therapy solutions for cancer specialty centers planning to treat from 250 to 2,000 patients annually with protons. The Proteus® series of Proton Therapy solutions can accommodate disparate budgets, building sites,...
Press Releases
TerraMedica To Become Fortel Analytics Fortel Analytics
Effective today, TerraMedica has changed its name to Fortel Analytics to reflect their focus on managing healthcare fraud and abuse prevention through advancing new and innovative predictive solutions, analysis methods and analytical technology. “Today we are...
Press Releases
Merck Sells Its Interest in Johnson & Johnson-Merck Consumer Pharmaceuticals
Merck, known outside the United States and Canada as MSD, today announced that the company has sold its 50 percent interest in the Johnson & Johnson--Merck Consumer Pharmaceuticals Co. joint venture to Johnson & Johnson affiliates, McNEIL-PPC, Inc., McNEIL...
Press Releases
Health Discovery Corporation Announces Issuance of First Patent Covering Prostate Cancer Biomarkers
Health Discovery Corporation is pleased to announce that the United States Patent and Trademark Office has issued the first of what the Company expects to be several patents covering methods to screen for the presence of prostate cancer using...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read